361 related articles for article (PubMed ID: 18759501)
1. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
[TBL] [Abstract][Full Text] [Related]
2. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
3. Irreversible inactivation of arylamine N-acetyltransferases in the presence of N-hydroxy-4-acetylaminobiphenyl: a comparison of human and hamster enzymes.
Wang H; Wagner CR; Hanna PE
Chem Res Toxicol; 2005 Feb; 18(2):183-97. PubMed ID: 15720122
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
Guo Z; Wagner CR; Hanna PE
Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
6. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system.
Oda Y
Mutat Res; 2004 Oct; 554(1-2):399-406. PubMed ID: 15450435
[TBL] [Abstract][Full Text] [Related]
10. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
11. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
12. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
13. Cyanamide-mediated Inhibition of N-acetyltransferase 1.
Dierolf D; Scheitza S; Bonifas J; Blömeke B
Toxicology; 2012 Dec; 302(1):1-10. PubMed ID: 22835378
[TBL] [Abstract][Full Text] [Related]
14. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.
King RS; Teitel CH; Kadlubar FF
Carcinogenesis; 2000 Jul; 21(7):1347-54. PubMed ID: 10874013
[TBL] [Abstract][Full Text] [Related]
15. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
Ragunathan N; Dairou J; Pluvinage B; Martins M; Petit E; Janel N; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2008 Jun; 73(6):1761-8. PubMed ID: 18310302
[TBL] [Abstract][Full Text] [Related]
16. The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kinetics.
Ragunathan N; Busi F; Pluvinage B; Sanfins E; Dupret JM; Rodrigues-Lima F; Dairou J
FEBS Lett; 2010 Aug; 584(15):3366-9. PubMed ID: 20591428
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram.
Malka F; Dairou J; Ragunathan N; Dupret JM; Rodrigues-Lima F
FEBS J; 2009 Sep; 276(17):4900-8. PubMed ID: 19664055
[TBL] [Abstract][Full Text] [Related]
18. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress.
Dairou J; Malecaze F; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2005 Apr; 67(4):1299-306. PubMed ID: 15644493
[TBL] [Abstract][Full Text] [Related]
19. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
[TBL] [Abstract][Full Text] [Related]
20. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
